发明名称 |
GALECTIN-3 INHIBITOR (GAL-3M) IS ASSOCIATED WITH ADDITIVE ANTI-MYELOMA AND ANTI-SOLID TUMOR EFFECTS, DECREASED OSTEOCLASTOGENESIS AND ORGAN PROTECTION WHEN USED IN COMBINATION WITH PROTEASOME INHIBITORS |
摘要 |
The present invention includes a method for the treatment of myeloma comprising identifying a patient with myeloma and administering to the patient a synergistic, effective amount of a truncated, dominant negative form of Galectin-3 and a proteasome inhibitor. |
申请公布号 |
EP3102247(A1) |
申请公布日期 |
2016.12.14 |
申请号 |
EP20150742527 |
申请日期 |
2015.02.03 |
申请人 |
Texas Tech University System |
发明人 |
CHIRIVA-INTERNATI, Maurizio;FIGUEROA, Jose, A.;COBOS, Everardo |
分类号 |
A61K48/00;A61K38/07;A61P35/00 |
主分类号 |
A61K48/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|